TY - JOUR
T1 - Cardiovascular effect of 7.5% sodium chloride-dextran infusion after thermal injury
AU - Murphy, Joseph T.
AU - Horton, Jureta W.
AU - Purdue, Gary F.
AU - Hunt, John L.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1999/10
Y1 - 1999/10
N2 - Hypothesis: Clinical study can help determine the safety and cardiovascular and systemic effects of an early infusion of 7.5% sodium chloride in 6% dextran-70 (hypertonic saline-dextran-70 [HSD]) given as an adjuvant to a standard resuscitation with lactated Ringer (RL) solution following severe thermal injury. Design: Prospective clinical study. Selling: Intensive care unit of tertiary referral burn care center. Patients: Eighteen patients with thermal injury over more than 35% of the total body surface area (TBSA) (range, 36%-71%) were studied. Interventions: Eight patients (mean ± SEM, 48.2% ± 2% TBSA) received a 4-mL/kg HSD infusion approximately 3.5 hours (range, 1.5-5.0 hours) after thermal injury in addition to routine RL resuscitation. Ten patients (46.0% ± 6% TBSA) received RL resuscitation alone. Main Outcome Measures: Pulmonary artery catheters were employed to monitor cardiac function, while hemodynamic, metabolic, and biochemical measurements were taken for 24 hours. Results: Serum troponin I levels, while detectable in all patients, were significantly lower after HSD compared with RL alone (mean ± SEM, 0.45 ± 0.32 vs 1.35 ± 0.35 μg/L at 8 hours, 0.88 ± 0.55 vs 2.21 ± 0.35 μg/L at 12 hours). While cardiac output increased proportionately between 4 and 24 hours in both groups (from 5.79 ± 0.8 to 9.45 ± 1.1 L/min [mean ± SEM] for HSD vs from 5.4 ± 0.4 to 9.46 ± 1.22 L/min for RL), filling pressure (central venous pressure and pulmonary capillary wedge pressure) remained low for 12 hours after HSD infusion (P= .048). Total fluid requirements at 8 hours (2.76 ± 0.7 mL/kg per each 1% TBSA burned [mean ± SEMI for HSD vs 2.67 ± 0.24 mL/kg per each 1% TBSA burned for RL) and 24 hours (6.11 ± 4.4 vs 6.76 ± 0.75 mL/kg per each 1% TBSA burned) were similar. Blood pressure remained unchanged, and serum sodium levels did not exceed 150 ± 2 mmol/L (mean ± SD) in either group. Conclusions: The absence of deleterious hemodynamic or metabolic side effects following HSD infusion in patients with major thermal injury confirms the safety of this resuscitation strategy. Postburn cardiac dysfunction was demonstrated in all burn patients through the use of cardiospecific serum markers and pulmonary artery catheter monitoring. Early administration of HSD after a severe thermal injury may reduce burn-related cardiac dysfunction, but it had no effect on the volume of resuscitation or serum biochemistry values.
AB - Hypothesis: Clinical study can help determine the safety and cardiovascular and systemic effects of an early infusion of 7.5% sodium chloride in 6% dextran-70 (hypertonic saline-dextran-70 [HSD]) given as an adjuvant to a standard resuscitation with lactated Ringer (RL) solution following severe thermal injury. Design: Prospective clinical study. Selling: Intensive care unit of tertiary referral burn care center. Patients: Eighteen patients with thermal injury over more than 35% of the total body surface area (TBSA) (range, 36%-71%) were studied. Interventions: Eight patients (mean ± SEM, 48.2% ± 2% TBSA) received a 4-mL/kg HSD infusion approximately 3.5 hours (range, 1.5-5.0 hours) after thermal injury in addition to routine RL resuscitation. Ten patients (46.0% ± 6% TBSA) received RL resuscitation alone. Main Outcome Measures: Pulmonary artery catheters were employed to monitor cardiac function, while hemodynamic, metabolic, and biochemical measurements were taken for 24 hours. Results: Serum troponin I levels, while detectable in all patients, were significantly lower after HSD compared with RL alone (mean ± SEM, 0.45 ± 0.32 vs 1.35 ± 0.35 μg/L at 8 hours, 0.88 ± 0.55 vs 2.21 ± 0.35 μg/L at 12 hours). While cardiac output increased proportionately between 4 and 24 hours in both groups (from 5.79 ± 0.8 to 9.45 ± 1.1 L/min [mean ± SEM] for HSD vs from 5.4 ± 0.4 to 9.46 ± 1.22 L/min for RL), filling pressure (central venous pressure and pulmonary capillary wedge pressure) remained low for 12 hours after HSD infusion (P= .048). Total fluid requirements at 8 hours (2.76 ± 0.7 mL/kg per each 1% TBSA burned [mean ± SEMI for HSD vs 2.67 ± 0.24 mL/kg per each 1% TBSA burned for RL) and 24 hours (6.11 ± 4.4 vs 6.76 ± 0.75 mL/kg per each 1% TBSA burned) were similar. Blood pressure remained unchanged, and serum sodium levels did not exceed 150 ± 2 mmol/L (mean ± SD) in either group. Conclusions: The absence of deleterious hemodynamic or metabolic side effects following HSD infusion in patients with major thermal injury confirms the safety of this resuscitation strategy. Postburn cardiac dysfunction was demonstrated in all burn patients through the use of cardiospecific serum markers and pulmonary artery catheter monitoring. Early administration of HSD after a severe thermal injury may reduce burn-related cardiac dysfunction, but it had no effect on the volume of resuscitation or serum biochemistry values.
UR - http://www.scopus.com/inward/record.url?scp=0032874854&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032874854&partnerID=8YFLogxK
U2 - 10.1001/archsurg.134.10.1091
DO - 10.1001/archsurg.134.10.1091
M3 - Article
C2 - 10522853
AN - SCOPUS:0032874854
SN - 2168-6254
VL - 134
SP - 1091
EP - 1097
JO - JAMA Surgery
JF - JAMA Surgery
IS - 10
ER -